PET Detection of CCR2 in Human Atherosclerosis
NCT04537403
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Carotid Atherosclerosis
Interventions
DRUG:
Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine)
DRUG:
Group 2 64CU-DOTA-ECL1i (radioactive imaging medicine)
Sponsor
Washington University School of Medicine